ENDOGEN ApS: Financial statements 2017
CVR: 29813337
Source: annual report 2017, Danish Business Authority
27/10/2016 – 26/10/2017
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -6,859 and a net result of DKK -7,059 compared with DKK -13,532 the year before. Equity in the 2017 report amounted to DKK 35,530. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -6,859
- Profit/Loss
- DKK -7,059
- Equity
- DKK 35,530
- Total Assets
- DKK 35,530
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
Keep an eye on ENDOGEN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ENDOGEN ApS has published its annual report for 2016. Revenue came to DKK 0, and the net result was DKK -13,532.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.